The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE postpones vehicle licensing limit for residents
UAE Government Annual Meetings key to reviewing national priorities
New pedestrian bridge links Dubai Mall Metro Station and Coca-Cola Arena
High-achieving Union teams honoured at UAE Government Annual Meetings
Al Gergawi: UAE accelerates development with over AED 4 trillion in projects
